Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2003
Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidineTanja Richter, Thomas E Mürdter, Georg Heinkele, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 20, 2005
Optimization of the TRAP assay to evaluate specificity of telomerase inhibitorsKamilla Piotrowska, Elke Kleideiter, Thomas E Mürdter, et al.
Pharmacogenetics|September 30, 2003
Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6Julia Kirchheiner, Christian Klein, Ingolf Meineke, et al.
Analytical and Bioanalytical Chemistry|July 25, 2015
Highly sensitive simultaneous quantification of estrogenic tamoxifen metabolites and steroid hormones by LC-MS/MSJanina Johänning, Georg Heinkele, Jana C Precht, et al.
Molecular Cancer|June 29, 2010
Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblastsSilke Haubeiss, Jens O Schmid, Thomas E Mürdter, et al.
Lung Cancer (Amsterdam, Netherlands)|August 22, 2009
Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cellsJulia Beisner, Meng Dong, Sebastian Taetz, et al.
Frontiers in Pharmacology|June 11, 2019
Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its MetabolitesZahra Khalaj, Zohreh Baratieh, Parvaneh Nikpour, et al.
British Journal of Clinical Pharmacology|December 18, 2003
Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicityJanet K Coller, Niels Krebsfaenger, Kathrin Klein, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugationMonika Bredschneider, Kathrin Klein, Thomas E Mürdter, et al.
BMC Cancer|December 17, 2008
Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breastMaike Sonnenberg, Heiko van der Kuip, Silke Haubeis, et al.
Pageof 7